GENEVA, April 29 -- MEIRAGTX NEURO I, LLC (655 Third AvenueSuite 1115New York, New York 10017) filed a patent application (PCT/US2025/050923) for "HIGH-DOSE GAD GENE THERAPY FOR TREATING PARKINSON'S DISEASE" on Oct 14, 2025. With publication no. WO/2026/085129, the details related to the patent application was published on Apr 23, 2026.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): FORBES, Alexandria (c/o MeiraGTx LLC655 Third AvenueSuite 1115New York, New York 10017)
Abstract: Provided herein are compositions and methods for treating or preventing neurodegenerative disease and for treating or ...